2.4.1.288: galactofuranosylgalactofuranosylrhamnosyl-N-acetylglucosaminyl-diphospho-decaprenol beta-1,5/1,6-galactofuranosyltransferase
This is an abbreviated version!
For detailed information about galactofuranosylgalactofuranosylrhamnosyl-N-acetylglucosaminyl-diphospho-decaprenol beta-1,5/1,6-galactofuranosyltransferase, go to the full flat file.
Word Map on EC 2.4.1.288
-
2.4.1.288
-
galactan
-
mycobacterial
-
tuberculosis
-
galf
-
polysaccharide
-
udp-galf
-
udp-galactofuranose
-
glycosyltransferases
-
arabinogalactan
-
glycoconjugate
-
mycolic
-
trisaccharide
-
tetrasaccharide
-
mycolyl-arabinogalactan-peptidoglycan
-
galactosyltransferase
-
polymerizing
-
l-arabinofuranose
-
galactomannans
-
anti-tuberculosis
-
fungal-type
- 2.4.1.288
- galactan
-
mycobacterial
- tuberculosis
-
galf
- polysaccharide
-
udp-galf
- udp-galactofuranose
- glycosyltransferases
- arabinogalactan
- glycoconjugate
-
mycolic
- trisaccharide
- tetrasaccharide
-
mycolyl-arabinogalactan-peptidoglycan
-
galactosyltransferase
-
polymerizing
- l-arabinofuranose
- galactomannans
-
anti-tuberculosis
-
fungal-type
Reaction
28 UDP-alpha-D-galactofuranose + = 28 UDP +
Synonyms
galactofuranosyl transferase 2, galactofuranosyltransferase, galactosyl transferase, GalTr, GlfT, GlfT2, LmjF.25.0010, LMJF_25_0010, LPG1, LPG1G, LPG1G2, LPG1L, Rv3808c
ECTree
Advanced search results
Inhibitors
Inhibitors on EC 2.4.1.288 - galactofuranosylgalactofuranosylrhamnosyl-N-acetylglucosaminyl-diphospho-decaprenol beta-1,5/1,6-galactofuranosyltransferase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
(1S,2S,3S,4S,5R)-1-[(1S)-1,2-dihydroxyethyl]-4-[[(furan-2-yl)methyl]amino]bicyclo[3.1.0]hexane-2,3-diol
UDP-Gal analogue, 82% inhibition at 4 mM
(2R,3R,4R,5R)-2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-3-yl hydrogen ((E)-((3R,4R,5S)-5-((R)-1,2-dihydroxyethyl)-3,4-dihydroxydihydrofuran-2(3H)-ylidene)fluoromethyl)phosphonate
-
(2R,3R,4R,5R)-2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-3-yl hydrogen ((Z)-((3R,4R,5S)-5-((R)-1,2-dihydroxyethyl)-3,4-dihydroxydihydrofuran-2(3H)-ylidene)fluoromethyl)phosphonate
-
(3S,4S)-3-(1,2-dihydroxyethyl)-4-hydroxy-1-(2-phenylethyl)tetrahydrothiophenium chloride
sulfonium ion compound as analogue of the donor substrate, uridine diphosphategalactofuranose. The compound contains moieties that mimic both galactofuranose and uridine diphosphate domains, and carries a permanent positive charge to mimic the oxocarbenium ion-like transition state. About 60% inhibition at 4 mM
(3S,4S)-3-(1,2-dihydroxyethyl)-4-hydroxy-1-[2-(4-nitrophenyl)ethyl]tetrahydrothiophenium bromide
sulfonium ion compound as analogue of the donor substrate, uridine diphosphategalactofuranose. The compound contains moieties that mimic both galactofuranose and uridine diphosphate domains, and carries a permanent positive charge to mimic the oxocarbenium ion-like transition state. About 50% inhibition at 4 mM
2-[(5E)-5-[(3,4-dichlorophenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-(4-iodophenyl)propanoic acid
UDP-galactopyranose mutase inhibitor, binding energy value of -8.08 kcal/mol. Compound passes the ADME evaluation and the predicted toxicity evaluation
UDP-3''-deoxy-alpha-D-xylo-hexofuranose
-
68% inhibition at 1.25 mM
UDP-5''-O-methyl-alpha-D-galactofuranose
-
15% inhibition at 1.25 mM
UDP-6''-O-methyl-alpha-D-galactofuranose
-
26% inhibition at 1.25 mM
additional information
-
not inhibited by UDP-2''-O-methyl-alpha-D-galactofuranose
-